Scilex Holding Co (SCLX)
0.843
-0.01
(-1.20%)
USD |
NASDAQ |
May 01, 16:00
0.844
0.00 (0.00%)
Pre-Market: 20:00
Scilex Free Cash Flow (Quarterly): -5.557M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.557M |
| September 30, 2023 | 5.745M |
| June 30, 2023 | -13.48M |
| March 31, 2023 | -7.744M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.725M |
| September 30, 2022 | 2.526M |
| June 30, 2022 | -14.40M |
| March 31, 2022 | -10.73M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-14.40M
Minimum
Jun 2022
5.745M
Maximum
Sep 2023
-5.545M
Average
-6.650M
Median
Free Cash Flow (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | -55.80M |
| Adial Pharmaceuticals Inc | -1.223M |
| Precision BioSciences Inc | -8.418M |
| Humacyte Inc | -19.20M |
| Perspective Therapeutics Inc | -9.097M |